NATCO Pharma introduced the release of the primary customary version of Nexavar (Sorafenib) Tablets in two hundred mg energy inside the US market. The product can be launched via NATCO’s commercial accomplice Viatris, a international pharmaceutical corporation.
Sorafenib is prescribed for treatment of unresectable Hepatocellular Carcinoma (HCC), superior Renal Cell Carcinoma (RCC) and Differentiated Thyroid Carcinoma (DTC). For more records talk over with the overall prescribing information or other scientific assets.
Nexavar registered sales of USD 69.7 million for the year ending December 2021 as in keeping with industry income statistics.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
